Hypoxia-Inducible Factor-Proline Dioxygenases
"Hypoxia-Inducible Factor-Proline Dioxygenases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Dioxygenase enzymes that specifically hydroxylate a PROLINE residue on the HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT. They are OXYGEN-dependent enzymes that play an important role in mediating cellular adaptive responses to HYPOXIA.
Descriptor ID |
D064799
|
MeSH Number(s) |
D08.811.682.690.416.617.500 D08.811.682.690.708.694.500
|
Concept/Terms |
Hypoxia-Inducible Factor-Proline Dioxygenases- Hypoxia-Inducible Factor-Proline Dioxygenases
- Dioxygenases, Hypoxia-Inducible Factor-Proline
- Factor-Proline Dioxygenases, Hypoxia-Inducible
- Hypoxia Inducible Factor Proline Dioxygenases
- HIF Prolyl-4-Hydroxylases
- HIF Prolyl 4 Hydroxylases
- Prolyl-4-Hydroxylases, HIF
- Hypoxia-Inducible Factor-Proline Dioxygenase
- Dioxygenase, Hypoxia-Inducible Factor-Proline
- Factor-Proline Dioxygenase, Hypoxia-Inducible
- Hypoxia Inducible Factor Proline Dioxygenase
- HIF Prolyl-4-Hydroxylase
- HIF Prolyl 4 Hydroxylase
- Prolyl-4-Hydroxylase, HIF
|
Below are MeSH descriptors whose meaning is more general than "Hypoxia-Inducible Factor-Proline Dioxygenases".
Below are MeSH descriptors whose meaning is more specific than "Hypoxia-Inducible Factor-Proline Dioxygenases".
This graph shows the total number of publications written about "Hypoxia-Inducible Factor-Proline Dioxygenases" by people in this website by year, and whether "Hypoxia-Inducible Factor-Proline Dioxygenases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2016 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
2021 | 0 | 2 | 2 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypoxia-Inducible Factor-Proline Dioxygenases" by people in Profiles.
-
Debate: Are HIF Stabilizers a Viable Alternative to ESAs in the Management of Anemia in CKD? PRO. Am J Nephrol. 2022; 53(5):361-365.
-
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis. N Engl J Med. 2021 12 16; 385(25):2313-2324.
-
Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis. N Engl J Med. 2021 12 16; 385(25):2325-2335.
-
Prolyl-hydroxylase inhibitors for the treatment of anemia in chronic kidney disease. Curr Opin Nephrol Hypertens. 2019 11; 28(6):600-606.
-
Prolyl hydroxylase domain proteins regulate bone mass through their expression in osteoblasts. Gene. 2016 Dec 05; 594(1):125-130.